Growth Metrics

Ligand Pharmaceuticals (LGND) EBT Margin Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 441.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7,297.00
10 Ligand Pharmaceuticals 4.55 Bn 3.77 Bn 48.45 Mn -17,318.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17,318.00
Dec 31, 2025 4,725.00
Sep 30, 2025 10,138.00
Jun 30, 2025 629.00
Mar 31, 2025 -8,565.00
Dec 31, 2024 -12,326.00
Sep 30, 2024 -3,780.00
Jun 30, 2024 -19,968.00
Mar 31, 2024 35,385.00
Dec 31, 2023 3,912.00
Sep 30, 2023 -920.00
Jun 30, 2023 -5,586.00
Mar 31, 2023 21,800.00
Dec 31, 2022 7,819.00
Sep 30, 2022 10,096.00
Jun 30, 2022 8,943.00
Mar 31, 2022 -196,303.00
Dec 31, 2021 12,700.00
Sep 30, 2021 -14,794.00
Jun 30, 2021 -6,392.00
Mar 31, 2021 -8,612.00
Dec 31, 2020 -2,974.00
Sep 30, 2020 -5,418.00
Jun 30, 2020 5,867.00
Mar 31, 2020 -10,275.00
Dec 31, 2019 -4,921.00
Sep 30, 2019 -8,570.00
Jun 30, 2019 -2,066.00
Mar 31, 2019 190,570.00
Dec 31, 2018 -12,280.00
Sep 30, 2018 13,235.00
Jun 30, 2018 -1,489.00
Mar 31, 2018 9,900.00
Dec 31, 2017 2,098.00
Sep 30, 2017 2,042.00
Jun 30, 2017 -248.00
Mar 31, 2017 -244.00
Dec 31, 2016 532.00
Sep 30, 2016 -997.00
Jun 30, 2016 -9,120.00
Mar 31, 2016 2,052.00
Dec 31, 2015 2,053.00
Sep 30, 2015 4,197.00
Jun 30, 2015 19,052.00
Mar 31, 2015 1,321.00
Dec 31, 2014 -807.00
Sep 30, 2014 7,841.00
Jun 30, 2014 2,206.00
Mar 31, 2014 11,894.00
Dec 31, 2013 5,389.00
Sep 30, 2013 16,215.00